Turner J R, Preston D A, Wold J S
Antimicrob Agents Chemother. 1977 Jul;12(1):67-72. doi: 10.1128/AAC.12.1.67.
By conventional laboratory evaluation procedures, the in vitro antibacterial activities of cefamandole and its O-formyl ester, cefamandole nafate, appear virtually identical. When the activities of these two compounds were examined for their ability to lyse log-phase cultures of susceptible bacteria, however, cefamandole was found to be about 10 times more active than cefamandole nafate. Cefamandole nafate was shown to be rapidly converted to cefamandole in bacteriological media, with a half-life of less than 1 h at a pH of 7.0 or above. At pH 6.0, in log-phase inhibition experiments, however, cefamandole nafate is more stable, allowing delineation of the activity between cefamandole and cefamandole nafate. The efficacy of cefamandole was identical to that of cefamandole nafate in treating experimental animal infections, indicating that rapid conversion of cefamandole nafate to cefamandole occurs in vivo.
通过传统的实验室评估程序,头孢孟多及其O - 甲酰酯头孢孟多酯钠的体外抗菌活性实际上看起来是相同的。然而,当检测这两种化合物裂解敏感细菌对数期培养物的能力时,发现头孢孟多的活性比头孢孟多酯钠高约10倍。头孢孟多酯钠在细菌学培养基中被证明能迅速转化为头孢孟多,在pH值为7.0或更高时半衰期小于1小时。然而,在pH 6.0的对数期抑制实验中,头孢孟多酯钠更稳定,从而能够区分头孢孟多和头孢孟多酯钠的活性。在治疗实验动物感染方面,头孢孟多的疗效与头孢孟多酯钠相同,这表明头孢孟多酯钠在体内能迅速转化为头孢孟多。